The store will not work correctly when cookies are disabled.
5-Acetylamino-1-(3-methylbenzoyl)-1H-indazole-3-carboxylic Acid ethyl ester
ID: ALA2409570
PubChem CID: 71818831
Max Phase: Preclinical
Molecular Formula: C20H19N3O4
Molecular Weight: 365.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1nn(C(=O)c2cccc(C)c2)c2ccc(NC(C)=O)cc12
Standard InChI: InChI=1S/C20H19N3O4/c1-4-27-20(26)18-16-11-15(21-13(3)24)8-9-17(16)23(22-18)19(25)14-7-5-6-12(2)10-14/h5-11H,4H2,1-3H3,(H,21,24)
Standard InChI Key: JKEDHQNDVWMJPW-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
4.6293 -18.9893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6282 -19.8089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3362 -20.2178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3344 -18.5805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0431 -18.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0433 -19.8089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8246 -20.0658 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3100 -19.3969 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8255 -18.7317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8110 -20.8814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0959 -21.2770 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5111 -21.3029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4939 -22.1186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1932 -22.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9092 -22.1443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9216 -21.3230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2217 -20.9053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1998 -18.0053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0161 -17.9663 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4581 -18.6536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7579 -17.3179 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6353 -20.9249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2743 -18.6146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9215 -18.5809 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2139 -18.9897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5061 -18.5813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2141 -19.8069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 2 0
10 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
18 19 1 0
19 20 1 0
18 21 2 0
16 22 1 0
20 23 1 0
1 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 365.39 | Molecular Weight (Monoisotopic): 365.1376 | AlogP: 3.17 | #Rotatable Bonds: 4 |
Polar Surface Area: 90.29 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.77 | CX LogD: 2.77 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.72 | Np Likeness Score: -1.61 |
References
1. Crocetti L, Schepetkin IA, Cilibrizzi A, Graziano A, Vergelli C, Giomi D, Khlebnikov AI, Quinn MT, Giovannoni MP.. (2013) Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase., 56 (15): [PMID:23844670] [10.1021/jm400742j] |